Ensuring Diagnostic Excellence This Flu Season: Independent QC Controls for Respiratory Testing

As the respiratory season intensifies, diagnostic laboratories are facing renewed pressure to deliver high-throughput, accurate results for an expanding list of respiratory pathogens. With co-circulating influenza, RSV, and SARS-CoV-2, and the ongoing threat of emerging strains, assay reliability and data integrity have never been more crucial.

The Challenge for Consistent Respiratory Testing

Respiratory diagnostics today encompass multiple technologies, from molecular assays to antigen detection systems. Variability between reagent lots, instrument calibration, or extraction efficiency can subtly impact performance. In periods of peak demand, even small deviations can cascade into significant analytical uncertainty, compromising confidence in results and accreditation readiness.

Why Independent QC Controls Matter

Third-party quality control materials play a vital role in verifying diagnostic performance across platforms. Unlike manufacturer-provided controls, independent QC materials such as those from Microbiologics are not optimised for any one assay. Instead, they behave like true patient samples, giving laboratories an unbiased, cross-platform assessment of analytical accuracy and reproducibility.
This aligns with ISO 15189:2012 recommendations, which encourage the inclusion of external or third-party controls to enhance the objectivity of quality assessments.

Simplifying QC Testing this Flu Season

QC testing shouldn’t add to your workload this flu season. Microbiologics simplifies the process with a range of ready-to-use, inactivated, test-ready controls covering a wide spectrum of respiratory and gastrointestinal (GI) pathogens. Each control is designed for consistent performance, stability, and ease of integration into existing diagnostic workflows.

Microbiologics Control Panels: Designed for Accuracy

Below is a selection of Microbiologics QC Respiratory and G.I. Panels available through Medical Supply Company:

These panels help laboratories verify assay precision across a comprehensive range of respiratory targets, including influenza A/B, RSV, SARS-CoV-2, and M. tuberculosis — ensuring results remain consistent even under heavy seasonal testing loads.

Best Practices for Implementation

To get the best from your QC materials:

• Select panels aligned with your diagnostic platform and target panel.
• Run QC samples alongside patient specimens to monitor ongoing performance.
• Record and trend QC data to support accreditation audits and identify subtle shifts early.
• Rotate between positive and negative panels to test both sensitivity and specificity.

Future-Proofing Laboratory Quality

With increasing multiplex assay complexity and evolving respiratory threats, QC materials must keep pace. Laboratories adopting independent, multi-analyte control panels are positioning themselves for long-term success, maintaining analytical precision, regulatory confidence, and public-health readiness.

Get In Touch